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Abstract
Background: The Spanish National Health System recognised multidisciplinary care as a health priority in 2006,
when a national strategy for promoting quality in cancer care was first published. This institutional effort is being
implemented on a co-operative basis within the context of Spain’s decentralised health care system, so a high
degree of variability is to be expected. This study was aimed to explore the views of professionals working with
multidisciplinary cancer teams and identify which barriers to effective team work should be considered to ensure
implementation of health policy.
Methods: Qualitative interview study with semi-structured, one-to-one interviews. Data were examined inductively,
using content analysis to generate categories and an explanatory framework. 39 professionals performing their
tasks, wholly or in part, in different multidisciplinary cancer teams were interviewed. The breakdown of participants’
medical specialisations was as follows: medical oncologists (n = 10); radiation oncologists (n = 8); surgeons (n = 7);
pathologists or radiologists (n = 6); oncology nurses (n = 5); and others (n = 3).
Results: Teams could be classified into three models of professional co-operation in multidisciplinary cancer care,
namely, advisory committee, formal co-adaptation and integrated care process. The following barriers to
implementation were posed: existence of different gateways for the same patient profile; variability in development
and use of clinical protocols and guidelines; role of the hospital executive board; outcomes assessment; and the
recording and documenting of clinical decisions in a multidisciplinary team setting. All these play a key role in the
development of cancer teams and their ability to improve quality of care.
Conclusion: Cancer team development results from an specific adaptation to the hospital environment.
Nevertheless, health policy plays an important role in promoting an organisational approach that changes the way
in which professionals develop their clinical practice.
Background
The increasing complexity of cancer care makes organi-
sation of clinical decision-making one of the key ele-
ments in high-quality cancer care [1]. This raises the
question of how good professional co-operation is to be
achieved in day-to-day clinical practice. Pre-eminent
among the different answers to this question is multidis-
ciplinary teamwork, an approach that has emerged in
parallel with the accelerated process of specialisation in
cancer among health professionals. Recent reviews of
the literature have associated a multidisciplinary
approach to cancer care with better adherence to clini-
cal practice guidelines [2], increased patient access to
clinical trials [3] and enhanced co-ordination of hospital
services [4,5]. These outcomes, together with the role
assigned to multidisciplinary care in various cancer
plans, indicate its strategic role for health systems in
general and for quality of care in particular in the orga-
nisation of cancer services, something that was high-
lighted at the Lisbon round-table held under the
Portuguese EU Presidency (2007) [6].
The development of multidisciplinary cancer care
involves a redistribution of health professionals’ tasks
when it comes to clinical decision-making and patient
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care processes. The development of specific organisa-
tional frameworks for dealing with different types of
cancer care must be seen in the context of a services-
based hospital structure. This process modifies a highly
sensitive aspect, i.e., the way in which professionals
interact and are co-ordinated. The following are the
main aspects defining a multidisciplinary approach in
the organisation of cancer care:
- professional specialisation by disease (including diag-
nostic disciplines);
- standardisation of the process and clinical criteria in
guidelines and pathways;
- redistribution of tasks at a multidisciplinary-team
level; and,
- trend towards identifying and allocating specific
resources according to disease/organ
The Spanish National Health System (SNHS) recog-
nised multidisciplinary care as being a health priority as
far back as 2006, when a national strategy for promoting
quality in cancer care was first published [7]. As one of
its basic principles, this Cancer Strategy document stipu-
lates that cancer patients should be diagnosed and trea-
ted in the context of a multidisciplinary team (MDT),
and goes on to identify tumour boards as the main
mechanism for deciding and planning therapy. This insti-
tutional effort is being implemented on a co-operative
basis within the context of Spain’s decentralised health
care system. The priority assigned by the respective
regional health services to multidisciplinary care since
health service management became operationally decen-
tralised (2002) and the specific mode of organisation
introduced at each hospital, together determine the start-
ing point of the implementation of an MDT approach. A
high degree of variability is thus to be expected.
This study addresses the question of how multidisci-
plinary cancer care has been implemented and the criti-
cal factors linked to this process, with special stress laid
on the knowledge of policy required to ensure effective
team work. The study was undertaken against a com-
mon backdrop of a growing cancer care burden and a
rapidly expanding range of potentially effective treat-
ments, which involves “therapeutic dilemmas about
treatment options” [8]. A qualitative approach was cho-
sen in order to better understand the perceptions and
beliefs of all the professional partners involved at the
different public hospitals spread across the nation’s var-
ious health care regions.
Methods
Study design and setting
A qualitative research method was used in order to
describe health professionals’ points of view and experi-
ences of multidisciplinary cancer care, and explore the
barriers to be considered in future policy development.
As an MDT approach in cancer had not been previously
studied in the context of the Spanish health system, a
pilot test was deemed appropriate. The aim was to iden-
tify a set of analytical categories which, along with a
review of the literature, would define a theoretical basis
for the interviews. The pilot scheme was undertaken by
three teams at different hospitals in Catalonia, focusing
on different tumours (breast, lung and colorectal). In
order to ensure the relevance and appropriateness of the
categories yielded by the test, health professionals from
different disciplines were then asked to give their con-
sidered opinion. The methodology of analysis consisted
of semi-structured interviews conducted in situ from
October 2008 to January 2009 with professionals
involved in the diagnosis and treatment of cancer
patients at public hospitals of differing levels of impor-
tance, situated in the most populated regions of Spain,
namely, Andalusia, Catalonia, Madrid, Galicia and
Valencia. Participants were interviewed by an experi-
enced, qualitative researcher.
Recruitment
A total of thirty-nine health professionals were
recruited. They were deemed eligible in any case where
they performed their professional task, wholly or in part,
in an MDT. For the selection of informants and compo-
sition of the theoretical sample, three inclusion criteria
were established. To ensure that the views of different
health professionals could be explored, the first criterion
laid down that five medical specialisations had to be
covered in each region: these were medical oncology,
radiation oncology, surgery, pathology or radiology, and
oncology nursing (Table 1). The second criterion rein-
forced a systematic approach to the phenomenon under
Table 1 Detailed breakdown of the 39 professionals
interviewed
Medical specialisations: No. of professionals
Medical oncologist 10
Radiation oncologist 8
Surgeon 7
Radiologist/Pathologist 6
Nurse 5
Other (palliative care, gynaecologist) 3
Cancer site:
Breast 19
Colorectal 8
Lung 4
Other 8
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study, by insisting on the presence of three opinions
from each region (table 2). The third criterion took the
form of a restriction on interviewing professionals
belonging to the same team, with the aim of preventing
biased versions on the subject of study and so contri-
bute to the internal validity of our research.
Interviews
A semi-structured list of questions ensured that critical
points were covered in every interview. To elicit beliefs
and experiences, participants were given the necessary
flexibility to enable them to volunteer information on
topics that were relevant to them. The selected health
professionals were interviewed on a one-to-one basis for
60-100 minutes at their hospital offices. Interviews
started with a general question on the cancer team’s
approach and ended with a question on how multidisci-
plinary care could be promoted by health policy mea-
sures. No notes were taken by the researcher during the
interview; instead, all interviews were audio-taped and
transcribed in full by the researcher. These data were
then compiled into a documentary record and rendered
anonymous to protect confidentiality. Every transcrip-
tion was checked against its corresponding audio record
and accuracy was found to be good. A preliminary ana-
lysis was conducted after each interview.
Analysis
Interview data were examined inductively, using content
analysis to generate categories and an explanatory fra-
mework. Grounded theory methodology was considered
appropriate for describing the organisation and culture
of health professionals belonging to multidisciplinary
cancer teams. As our study was theoretical and aimed at
incorporating the organisational context in which cancer
teams practised, we used an axial coding, as described
by Strauss and Corbin [9]. Data were electronically
coded with ATLAS.ti [10]. Whereas the thematic analy-
sis enabled language use to be understood and profes-
sionals’ beliefs to be communicated, the method of
constant comparison ensured that recurring views and
experiences were obtained. The coding process and
emerging themes were derived, on the one hand, from a
priori issues drawn from the pilot test and previous
research, and on the other, from issues raised by partici-
pants. Examples of codes were “nature of agreements”,
“access of a patient to the team during his/her journey”
and “impact management on care performance”. The
consistency of coding/interpretation was checked during
analysis by reviewing the transcripts at different
moments in time. This process allowed for labelling and
developing a reference of the data for subsequent
exploration and identification. Accordingly, a thematic
framework based on models of and barriers to effective
multidisciplinary teamwork was identified. A specific
effort was made to capture this stage of interpretation,
i.e., by mapping, creating typologies [11] and finding
associations among themes. Moreover, the preliminary
findings were discussed at a workshop (held by the
scientific societies), to which some of the health profes-
sionals interviewed and a number of social science
researchers were invited. These discussions were useful
for reinforcing team types for the Spanish health system
and clarifying some barrier-related aspects.
Ethical considerations
The data for this study was based on professionally con-
ducted interviews which, other than the consent of the
professionals themselves, require no “ethical approval”
from any research committee. However, as the aim of
our study is sensitive to hospital organisation and rela-
tions between specialisations and health professionals,
confidentiality is of the essence. Accordingly, the strat-
egy pursued was to prioritise a selection of participants
whose opinion on these issues was deemed crucial, and
so, contact with regional cancer control policymakers
was made. The implementation of the study began
through contact with the heads of the regional cancer
plans, who proposed a short list of health professionals
selected in accordance with our criteria (see table 2).
Likewise, the resulting list was endorsed by the scientific
societies of medical and radiation oncology. The health
professionals concerned were then sent a letter of invita-
tion explaining the research goals and a confidentiality
agreement. On being advised by telephone and receiving
an assurance as to the confidentiality of any information
provided, all the professionals selected for study con-
sented to the interviews being recorded. The consent
form was formally signed at the meeting, with any
doubts as to the designated purpose and method of
research being discussed with the professionals. No-one
refused the invitation to participate.
Results
We identified three models of development of multidis-
ciplinary cancer care into which all teams could be clas-
sified (table 3). Their internal consistency means that
they can be seen as models of co-operation, and despite
Table 2 Profiles required for selection of key informants
From a process
standpoint
Professionals usually working with this type of
organisational approach
From a technical
standpoint
Professionals who have led organisational
change towards more integrated forms of
multidisciplinary cancer care
From an institutional
standpoint
Professionals who frame the situation of
multidisciplinary care within a hospital
management model
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being general categories, any given team model may well
contain elements of the other two. Moreover, the quali-
tative classification described here may even occur
within the same hospital for different teams, with each
of these assuming responsibility for a different tumour.
Rather than targeting specific forms of organisation
(tumour board, cancer unit), this approach focuses
instead on team capabilities, based on each team’s work
method and the overall scope (breadth and depth) of
the tasks performed, elements of analysis that emerged
during the study and indicate the nature of interaction
among professionals. While all cancer teams fulfilled the
role of assessing patients and complying with and
updating clinical protocols, obvious differences in their
respective abilities to achieve quality of care were never-
theless observed.
1.- Advisory committee
This is a group of professionals, largely made up of spe-
cialists in different therapeutic fields, which meets regu-
larly on a informal basis to discuss cases considered
clinically complex. Since the patients may already have
received some of the treatments (usually surgery), the
multidisciplinary meeting is aimed at referring them to
other professionals for further treatment. This approach
implies rigorous respect for the autonomy of the clini-
cian and for overlapping boundaries between the team
and the multidisciplinary meeting: patient assessment is
made without other health care performance considera-
tions. Judging by our results, this model continues to
enjoy an important presence in the system (40%).
2.- Formal co-adaptation
Owing to the high degree of interaction (mutual adapta-
tion) among the professionals involved, consensus plays
a key role in this model. The team acts as the reference
framework for professionals, who share their views on
the diagnosis, treatment and monitoring of a specific
cancer type. The meeting is open to all professionals
involved in patient management and it is here that the
roles of team tumour board co-ordinator and chair
appear. The key factor for fostering such an approach is
agreement on the need for: joint decision-making to
precede application of any treatment; and all cases to be
dealt with at the multidisciplinary meeting. Both aspects
are hampered, however, by hospital service inertia when
it comes to disease management. This formula accounts
for half (50%) of all MDT meetings in the health care
system.
3.- Integrated care process
The teams that work under this model share wide aims
on patient management, including co-ordination of clin-
ical research and economic evaluation of treatment. As
this model provides teams with early access to patients,
the latter’s preferences along with knowledge of their
co-morbidities and psychosocial context are incorpo-
rated into the multidisciplinary discussions. This occurs
through systematic follow-up of patients throughout
their journey, from suspicion of cancer, to diagnosis,
therapeutic decision-making and follow-up. The pre-
sence of professional team roles has an impact on the
entire care process and on progress towards achieving
Table 3 Models of co-operation in multidisciplinary cancer care
1. Advisory committee 2. Formal co-adaptation 3. Integrated care process
Cases submitted (approx. %) “Complex” cases or off-protocol:
10% - 50%
All “possible” cases: 50% - 80% Initial source of clinical assessment:
90%-100%
Patient access to team Treatment (whether or not
initiated)
Diagnosis or treatment Suspect or diagnosis (early access)
Nature of agreements Recommendations Consensus decisions not always
implemented
Binding decisions defended by the
team
Professional team roles Negative perception Chair, tumour board co-ordinator Chair, co-ordinator, nurse case
manager
Impact on clinical process management Minor changes Some segments of care Whole process (cross-boundary
frequent)
Specialist participation No diagnostic specialisations Absences due only to timetable
problems
Professionals associated with a
clinical committee
Junior doctors and nursing role, in terms
of attendance
Considered inappropriate Open meeting, participation
encouraged
Mandatory presence
Hospital executive board role Lack of interest Acknowledgement without
express support
Express support (room, clerk, etc.)
Presence in health system 40% 50% 10%
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seamless care. The hospital executive board plays a
pivotal role by consolidating meeting times, and ensur-
ing health professionals’ attendance as well as their
commitment to the MDT. This model is not frequent in
the system (10%).
Critical factors in multidisciplinary cancer team
development
For many clinicians, development of multidisciplinary
care has involved a cultural change, as can be seen from
the pathway which resulted from recommendations that
were proposed by cancer team members for clinical
management of patients and have gradually become
binding decisions. The key critical factors identified for
this change are as follows:
Existence of different gateways for the same patient profile
Many clinicians acknowledged significant variability in
clinical practice as a result of diagnosing and treating
patients who, despite having similar symptoms and diag-
noses, might receive different initial therapy because
access to hospital took place through different depart-
ments. A typical example is provided by the different
therapeutic approaches proposed to a prostate cancer
patient depending on the initial hospital department
responsible for his diagnosis. Although a shared clinical
protocol on such patients for the whole hospital plus an
agreement to submit the patient to the MDT meeting
would limit this variability, it is the unification of hospi-
tal-access gateways into a single hospital department
that would have the necessary transforming quality in
terms of standardisation of clinical criteria and path-
ways. Indeed, a recurring example of this type of organi-
sational change is afforded by unification of admission
to radiology for breast cancer or to gastroenterology for
colorectal cancer in the case of patients displaying
symptoms with a high risk of cancer. The experience of
agreeing upon a common gateway for suspects has three
effects: it provides teams with early access to patients; it
reduces the feeling of patients being the “property” of
any given clinician or department; and it sets up a pri-
mary care reference catchment area, as it becomes easier
and clearer to determine where and how subjects with
high risk of cancer should be referred and who the spe-
cialists of reference are. Moreover, where the depart-
ment taking on the gateway unification process of the
clinical pathway is a diagnostic unit, this implies that it
should have a more relevant role within the team.
“At the hospital, there is a breast cancer unit that is
beset by a root problem, i.e., two treatment options
depending on whether the patient has been admitted
via gynaecology or surgery. These are internal battles
waged by the respective competencies.” (Breast
surgeon)
“In this hospital there are two chairs of surgery: one
comes to the meetings, the other doesn’t. We know
that they administer different forms of treatment.
The percentage of cases in which this occurs is by no
means inconsiderable.” (Medical oncologist)
Variability in the development and use of clinical protocols
and guidelines
Evidence-based decisions are a source of concern to
professionals, and the updating of clinical protocols by
the team reflects this concern. Many clinicians felt, how-
ever, that this goal was conditioned by the implementa-
tion and dissemination of cancer clinical guidelines in
the Spanish Health System. They argued that the
absence of common guidelines for the whole country
and the lack of co-ordination strategies for implement-
ing the few that did exist resulted in reduced use and a
lack of systematic assessment of existing levels of adher-
ence. Owing to this perceived situation, clinical proto-
cols at a hospital level are very often based on foreign
guidelines, and efforts made to produce Spanish ones
are of little use. This in turn leads to three common
situations which impact at a team level. Firstly, hospitals
that refer cases (e.g., because of their clinical complex-
ity) have protocols based on different guidelines that are
not standardised across the health care system. Sec-
ondly, multidisciplinary cancer care displays different
levels of development, so that patients in one hospital
may be referred to a specific department, but not to the
tumour board, in another, the point here being the
absence of pre-specified criteria for referral among levels
of care. Thus, some decisions are made without the
scientific consensus of an MDT. Finally, a cancer team
might change the original treatment plan for a patient
referred from a lower level hospital. This was a concern
voiced by several clinicians, since decisions sometimes
tend to differ widely, causing confusion and lack of trust
in the patient. This perception was not shared by health
professionals who work for cancer networks.
“When a surgeon comes along saying that he has
operated on a given patient without the consensus of
the committee but -according to him- this course of
action was ‘in line with the evidence’... this is unac-
ceptable. It’s an issue to be addressed by the respec-
tive cancer plans. When guidelines are reviewed, this
should be the starting point, i.e., the tumour commit-
tee report should be seen before the surgical report.”
(Radiation oncologist)
The role of the hospital executive board
Most health professionals believed that, while they had
not been hampered by the hospital executive board,
neither had they been specifically supported to better
organise clinical pathways and MDT activity. In their
view, the main problem was that MDT work time was
Prades and Borràs BMC Public Health 2011, 11:141
http://www.biomedcentral.com/1471-2458/11/141
Page 5 of 10
not recognised as a health care activity (or “real work”
to quote them). Half of those interviewed felt that hos-
pital managers knew little about their tasks, goals, level
of involvement and management problems. These pro-
fessionals identified two clear priorities for hospital
executive boards, namely: to protect multidisciplinary
meetings and work time; and to promote new profes-
sional roles, such as nurse case-managers or administra-
tive support. Those with management responsibilities
stated that cancer teams were not reflected in the orga-
nisational chart but were very important in terms of
quality of care, and more innovative and responsive
insofar as health care organisation achievement was
concerned.
“If you tell management that you have to attend a
committee meeting, they view it as something that is
all well and good but nevertheless ancillary, and so
not meriting consideration as part of the daily work
load. Yet such attendance should be accorded health
care and scientific value, i.e., so many hours corre-
spond to committee work, which is equal to time
spent seeing patients in a medical practice.” (Colorec-
tal surgeon)
“Your personal efforts are not appreciated, regardless
of whether you’ve taken part in drawing up a proto-
col or whether you’ve devoted one day or three weeks
to the job... And, as no stress is laid on the impor-
tance of teamwork, there are pockets of resistance
that don’t change”. (Radiologist)
Outcome assessment
The main goal of any multidisciplinary cancer team is to
enhance the effectiveness of diagnosis and treatment of
a specific disease. Assessment of the MDTs that had
been put in place revealed relevant differences among
the views held by the professionals themselves. To most
of them, the ultimate consequence of the efforts of
some hospital units or specialised professionals that reg-
ularly collect clinical data was evaluation or a study
aimed at assessing MDT outcomes. Others, in contrast,
described process evaluation involving initial inter-
departmental consensus on indicators, development of a
specific data-collection methodology, and periodic analy-
sis of results using a shared database. Above all, this
situation defines different approaches to the possibility
of taking clinical outcomes and process indicators, and
linking these to actions aimed at improving cancer care.
There were two recurring arguments associated with
possible ways of achieving organisational change: the
first centred on the key role to be played by the health
care service in reaching a technical definition of and
agreement on a minimum set of indicators for the entire
hospital system and a proposed level of transparency
vis-à-vis outcomes; the second addressed the pervasive
“culture of efficiency” currently prevailing in hospital
departments, insisting on the need to limit its influence
and instead give increased relevance to clinical and pro-
cess indicators. An experience that has had remarkable
success in various health care regions and has served as
the basis for the evaluation of each MDT, is the imple-
mentation of a fast-track, colorectal, breast and lung
cancer diagnosis and treatment programme, a driving
force in promoting integration among services and
MDTs. Its implementation has shown the key role that
health care policy could play in enhancing the organisa-
tion of cancer care.
“The problem is that each specialisation has devel-
oped its own indicators of toxicity, clinical results,
etc. There should be at least one database in which
the team’s outcomes are reflected. This is something
that the hospital ought to demand. We could then
say in real time, ‘this, or that, is what’s happening in
prostate cancer’.” (Medical oncologist)
“Yesterday I saw 37 patients: I can’t devote myself to
recording that much information in the database
without any support... It’s difficult for everyone’s sur-
vival to be ascertained under such conditions. We
tend to move within a ‘dead’ database context, that’s
to say, we get together at the end of the year to see
how things have gone...” (Colorectal surgeon)
Recording and documenting of clinical decisions in an MDT
setting
The more formalised MDTs become, the more impor-
tant easy access to and transparency of decisions and
the rationale behind them are. The reason for this is
that recording decisions reflects the outcome of consen-
sus building and the value that professionals attribute to
their work. Half of all clinicians interviewed stated that
they noted their decisions on the electronic clinical
record. Not only does such action clearly define the
end-point of the decision-making process, it also renders
it more transparent, something that, in turn, generates a
positive perception of the entire hospital environment.
In contrast, there are many cases where team decisions
do not extend beyond the strict limits of the tumour
board, as shown by the first comment in Excerpt 5. The
major weaknesses in recording clinical decisions stem
from the lack of standardisation achieved in tumour-
board Minute-taking, due to absence of common forms,
failure to identify clear recording responsibilities and,
very often, lack of administrative support. What this
tends to mean is that only the decisions affecting of-
protocol patients are recorded, thus hindering the possi-
bility of establishing a reference database for a specific
cancer. One last very important aspect for any team is
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the recording of decisions made in those cases where
there is no consensus. Though infrequent, this situation
is thought to play a relevant role in terms of medico-
legal implications.
“In one of the hospital teams, there are professionals
who find it difficult to accept consensus-based deci-
sions. Accordingly, we consider it appropriate that, in
addition to the decision being recorded in the digital
clinical history, a file should be circulated to all
team members so that decisions taken with respect to
all patients are ‘known’ to them...” (Medical
oncologist)
“We keep a number of formal records, I mean to say
that there are several specialists who record details of
patients in their files... but there is no single overall
record.” (Nurse case manager)
“There is an element of administration (which should
be the task of a secretary) entailed in the drafting
and signing of Minutes. This is generally performed
by a physician, but if he’s absent for any reason, then
no-one does it. It’s always the same old story: it’s all
a matter of personal involvement.” (Pathologist)
Discussion
The reference to Jean-Baptiste Lamarck (1744-1829) in
the title of this article ("the function creates the organ”)
is a description that is both accurate and useful for
understanding the evolution of multidisciplinary cancer
care in the Spanish health system. In a manner similar
to the apocryphal example of Lamarck’s giraffe, which
craned its neck to match the height of the trees, the
development of cancer teams results from adaptation to
the immediate hospital environment accompanied by a
lack of policy orientation. While the law lays down that
all hospitals are to have cancer boards for the most pre-
valent diseases, no specific aims, organisational require-
ments or performance assessment standards have been
prescribed.
There is a valuable lesson to be learnt in the path
taken by the UK National Health Service. The publica-
tion of the Calman-Hine [12] report in 1995 highlighted
the importance of a successful institutional framework
for cancer services. As Haward [13,14] pointed out,
however, the effort to define their performance –
including multidisciplinary care– in detail [15], without
addressing the factors that were to facilitate the transi-
tion, resulted in slow, uneven change. The Spanish
experience failed to develop this type of learning pro-
cess. Our study therefore sought to identify the cultural
and organisational dimensions that influence the incor-
poration of planned actions. This approach is reinforced
by the EUROCARE-4 study, which identifies the organi-
sational elements in the care process by the latter’s
ability to improve the survival and quality of life of can-
cer patients, as evidenced by the differences among
European countries [16,17].
Impact on decision making
Implementation of multidisciplinary care involves a
redistribution of the responsibilities assumed by the
respective professionals, with the aim of developing
greater potential for enhancing their joint clinical effec-
tiveness. It is a specific organisational answer to the
complexity of cancer care, and enables new approaches
to be taken and known problems, such as variability in
clinical practice, to be tackled. In this connection, note
should be taken of the overall strategy adopted by the
National Breast and Ovarian Cancer Centre of Australia,
which, along with several other authors [18-20], identi-
fies multidisciplinary care with the standardisation of
clinical practice in the health system. Most professionals
interviewed by us regard MDT as the main tool for
ensuring that the expertise of each discipline is involved
in the clinical decision making process affecting any
given patient. Furthermore, high levels of adherence to
clinical protocols improve the efficiency of MD meetings
by better discerning the transition from simple to com-
plex case discussions.
Our study confirms previous research in underscoring
the high degree to which the effectiveness of multidisci-
plinary interventions is dependent on the organisational
context in which cancer care is delivered. Some techni-
cal aspects stressed are the need: for administrative sup-
port for team activity and organisation [8]; and for all
decisions taken to be entered into the electronic clinical
record, since failure to keep a record hinders application
of such decisions to the patient, as shown by a study
that targeted breast cancer teams in 2006 [21]. More-
over, a treatment-planning register can be helpful when
it comes to assessing similar cases or auditing an MDT’s
performance [22]. Nevertheless, the key factor is com-
munication among team members as a sign of profes-
sional team trust. This is the most relevant dimension
to be discerned in the above-described models of inte-
gration of clinical care. The fact that decisions should
be binding upon team members, that there is continued
participation by specialists in the meetings, that the
impact on the entire patient pathway is perceived as
positive, that there is a role for clinical co-ordinators
and nurse case managers, and that both residents and
nurses participate in training, are indicators of the abil-
ity of the clinicians involved to abandon a sequential
and relatively unco-ordinated model of cancer care and
progress instead towards achieving a model of integrated
care based on consensus decision-making.
Specialisation in a given area of cancer diagnosis and
treatment facilitates communication among different
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specialisations and professionals, through using specialist
knowledge and expertise as a departure point for
addressing specific patients rather than for the perfor-
mance of specific tasks. Experiences, such as reaching
an agreement on a common gateway for patients with
high-risk symptoms for cancer or protecting the time
for multidisciplinary teamwork, can also be key ground-
work for promoting effective team communication.
Other researchers emphasise aspects of the importance
of professional integration within cancer networks [23],
or the improvement in mental wellbeing and profes-
sional satisfaction that comes with MDT development,
as a result of lower anxiety and better feelings about
personal performance [24,25]. Another approach is also
the need to achieve consistent care from the standpoint
of the cancer patient [26]. This was well illustrated by
affording patients access to the MDT in the early stages
of the diagnostic process, a way of preventing the possi-
bility of initial treatment being administered without
team discussion, and communicational fragmentation
with the patient being increased.
Strengths and limitations
This study has some strengths and limitations that must
be taken into account when assessing its results. Insofar
as its strengths are concerned, it should be noted that,
rather than approaching MDTs from the standpoint of
the specific structures which frame teamwork, we sought
instead to understand MDTs from the standpoint of the
capabilities of the professionals and teams themselves.
This enabled us to obtain a better insight into the ways
in which professionals interacted and the nature of the
agreements and commitments reached within an MDT.
The synthesis of our results in the form of three models
of multidisciplinary cancer care to be found in Spain
facilitates the transfer of such findings to SNHS hospitals.
Indeed, as our study shows, multidisciplinary care dis-
plays significant variability in its methodology and degree
of implementation among hospitals and regions, but not
in the critical factors that have influenced its develop-
ment. These models have been checked with the health
professionals involved in the study.
A clear limitation of the study resides in the selection
process, based on proposals put forward by the chair-
men of scientific societies of medical and radiotherapy
oncology and the heads of regional cancer plans, which
could have biased our selection of professionals towards
those with sensitivity to multidisciplinary care and orga-
nisational change per se. The selection criteria vis-à-vis
the different profiles, plus the fact that major university
teaching hospitals were involved in the study, were
intended to minimise this limitation. Moreover, our
interpretation of the findings and the model proposed
here were discussed with different specialists, hospitals
and regions.
As with all qualitative studies, there was not a large
number of participants. Our research focused on the
views of key informants, thereby implicitly ruling out
the possibility of capturing all the experiences and best
practices that might exist in the health system. Lastly,
Table 4 Research metaphors
The “black box” This metaphor is often used by health professionals outside MD meetings because of little knowledge
of their internal functioning.
“The Lone Ranger” The “Lone Ranger doing ‘clinical justice’ is outdated but we still have many ‘Lone Rangers’ riding in
our health system”, says one interviewee. Lone Rangers, in this context, are clinicians who unilaterally
assume the management of cancer processes.
“Orchestra” vs. “Big Band Jazz” In the case of the orchestra, a multidisciplinary team requires a “baton to lead it”, a few “first violins to
give the health care symphony order and structure” and several “instruments” which may stand out to
a greater or lesser degree but must nevertheless all play in harmony so that the ensemble sounds
good as a whole. To this end, developing an internal organisation based on commonly shared rules
and roles is a crucial factor. Other professionals view “Big Band Jazz” as a more appropriate metaphor.
They understand the functioning of the multidisciplinary team in a much less rational and formalised
way, a human group in which improvisation and voluntary actions play a key role, with individual
creativity as an essential component for ensuring that the process has a good outcome.
“Partitions and walls” Professionals refer to the different metaphorical thickness of the partitions and walls to explain the
mental distances that often separate them.
“Main actors, supporting (secondary) actors,
and guests artists”
The feeling of playing specific roles in teams varies among professionals. Some of them express their
involvement in terms of being main actors, and others as supporting actors or guests artists who
attend the meeting only because they are invited.
The “snowball” The large volume of visits entailed in long-term follow-up of cancer survivors, equivalent to one third
of the time of activity for some professionals, leads them to refer to this process as a “snowball”. In
fact, one physician interviewed stated that, “you almost marry a patient with cancer”.
In “no man’s land” or “trapped between the
two health systems”
These expressions are used in cases where good practices for taking care of cancer survivors are seen
to be lacking, and the current intervention model is ineffective. Primary and specialised care are
organised and conceived without identifying specific needs and consistent responsibilities vis-à-vis
cancer survivors.
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mention should be made of the fact that one third of all
interviewees belonged to the field of breast cancer, a
disease that frequently becomes a model for others.
Conclusions
This is the first qualitative study of multidisciplinary
cancer care in southern Europe. The delay in MDT
implementation poses the need for health policy not
only to acknowledge and promote it, but also to provide
quality standards. In addition, there is a clear need to
respect and promote good practices existing in the
health care system. In this regard, this study may help
understand how professionals conceptualise this
approach, which is relevant when interest lies in devel-
oping more comprehensive care by placing multidisci-
plinary care at the core of cancer department, as stated
in Spain’s official cancer strategy. Moreover, metaphors
play a key role in the way professionals imagine and
explain teamwork in cancer care (table 4).
MDT development often entails a process of decentra-
lisation inside hospitals, which may involve some redis-
tribution of power. This is an adaptive challenge for
hospital managers in terms of clinical governance, i.e.,
making structures more permeable to organisation of
expertise without losing efficiency in the management of
shared resources. A culture of evaluation of clinical and
process outcomes should emerge, aimed at directing
and justifying organisational innovation so as to achieve
the best possible performance in terms of care of cancer
patients. Multidisciplinary care occurs simultaneously
with rapid changes in treatment and use of clinical prac-
tice guidelines, all of which makes it more difficult to
identify its specific advantages [27]. This is why health
policy plays an important role in promoting an organisa-
tional approach that changes the way in which profes-
sionals develop their clinical practice, a key issue in a
disease such as cancer, characterised by its clinical com-
plexity, involvement of different clinical specialists and
need to face the new challenge of managing patient
preferences.
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